Agios Pharmaceuticals, Inc. (AGIO)
28.85
+1.00
(+3.59%)
USD |
NASDAQ |
Mar 16, 16:00
27.80
-1.05
(-3.64%)
After-Hours: 20:00
Agios Pharmaceuticals Market Cap : 1.690B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 180.29B |
| Alnylam Pharmaceuticals, Inc. | 42.29B |
| CorMedix, Inc. | 517.78M |
| Enanta Pharmaceuticals, Inc. | 374.06M |
| Karyopharm Therapeutics, Inc. | 157.94M |
Market Cap Related Metrics
| PS Ratio | 30.95 |
| Price to Book Value | 1.417 |
| Price | 28.85 |
| Earnings Yield | -24.68% |